Differential in vivo clearance and response to secondary heterologous infections by H2 b-restricted dengue virus-specific CD8 + T cells

Viral Immunology

Volumn 23, Issue 5, 2010, Pages 477-485

  Beaumier, Coreen M ^a   Jaiswal, Smita ^a   West, Kim Y ^a   Friberg, Heather ^a   Mathew, Anuja ^a   Rothman, Alan L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 5; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; CYTOTOXICITY TEST; DENGUE; DENGUE VIRUS; ENZYME LINKED IMMUNOSPOT ASSAY; IN VIVO STUDY; MOUSE; NONHUMAN; SECONDARY INFECTION; SEROTYPE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY TESTS, IMMUNOLOGIC; DENGUE; DENGUE VIRUS; EPITOPES, T-LYMPHOCYTE; H-2 ANTIGENS; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA; VIRAL NONSTRUCTURAL PROTEINS;

DENGUE VIRUS; MUS;

EID: 77957726710     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2010.0034     Document Type: Article

References (43)

1. Godfrey DI, Stankovic S, and Baxter AG: Developing NKT cells need their calcium. Nat Immunol 2009;10:231-233.
2. Burke DS, Nisalak A, Johnson DE, and Scott RM: A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 1988;38:172-180.
3. Guzman MG, Kouri G, Martinez E, et al.: Clinical and serologic study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Bull Pan Am Health Organ 1987;21:270-279.
4. Sangkawibha N, Rojanasuphot S, Ahandrik S, et al.: Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 1984;120:653-669.
5. Thein S, Aung MM, Shwe TN, et al.: Risk factors in dengue shock syndrome. Am J Trop Med Hyg 1997;56:566-572.
6. Vaughn DW, Green S, Kalayanarooj S, et al.: Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000;181:2-9.
7. Halstead SB: In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis 1979;140:527-533.
8. Halstead SB, Shotwell H, Casals J: Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection. J Infect Dis 1973;128:7-14.
9. Halstead SB, Shotwell H, Casals J: Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. J Infect Dis 1973;128:15-22.
10. Bashyam HS, Green S, and Rothman AL: Dengue virusreactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J Immunol 2006;176:2817-2824.
11. Kurane I, Innis BL, Nisalak A, et al.: Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest 1989;83:506-513.
12. Mathew A, Kurane I, Rothman AL, et al.: Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J Clin Invest 1996;98:1684-1691.
13. Avirutnan P, Malasit P, Seliger B, et al.: Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 1998;161:6338-6346.
14. King CA, Anderson R, and Marshall JS: Dengue virus selectively induces human mast cell chemokine production. J Virol 2002;76:8408-8419.
15. Laoprasopwattana K, Libraty DH, Endy TP, et al.: Antibodydependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication. J Infect Dis 2007;195:1108-1116.
16. Shresta S, Kyle JL, Robert Beatty P, and Harris E: Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Virology 2004;319:262-273.
17. Shresta S, Kyle JL, Snider HM, et al.: Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T-and B-cell-dependent immunity are less critical. J Virol 2004;78:2701-2710.
18. Shresta S, Sharar KL, Prigozhin DM, et al.: Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J Immunol 2005;175:3946-3954.
19. An J, Kimura-Kuroda J, Hirabayashi Y, and Yasui K: Development of a novel mouse model for dengue virus infection. Virology 1999;263:70-77.
20. Bente DA, Melkus MW, Garcia JV, and Rico-Hesse R: Dengue fever in humanized NOD/SCID mice. J Virol 2005;79:13797-13799.
21. Huang KJ, S. Y. Li, S. C. Chen, et al. 2000 Manifestation of thrombocytopenia in dengue-2-virus-infected mice. J Gen Virol. 81:2177-2182.
22. Johnson AJ, and Roehrig JT: New mouse model for dengue virus vaccine testing. J Virol 1999;73:783-786.
23. Mota J, and Rico-Hesse R: Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J Virol 2009;83:8638-8645.
24. Lin YL, Liao CL, Chen LK, et al.: Study of Dengue virus infection in SCID mice engrafted with human K562 cells. J Virol 1998;72:9729-9737.
25. van der Most RG, Murali-Krishna K, Ahmed R, and Strauss JH: Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response. J Virol 2000;74:8094-8101.
26. Beaumier CM, Mathew A, Bashyam HS, and Rothman AL: Cross-reactive memory CD8 (+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner. J Infect Dis 2008;197:608-617.
27. Beaumier CM, and Rothman AL: Cross-reactive memory CD4+ T cells alter the CD8+ T-cell response to heterologous secondary dengue virus infections in mice in a sequence-specific manner. Viral Immunol 2009;22:215-219.
28. Gessner A, Blum H, and Rollinghoff M: Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Immunobiology 1993;189:419-435.
29. Locksley RM, Heinzel FP, Sadick MD, et al.: Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets. Ann Inst Pasteur Immunol 1987;138:744-749.
30. Yauch LE, Zellweger RM, Kotturi MF, et al.: A protective role for dengue virus-specific CD8+ T cells. J Immunol 2009;182:4865-4873.
31. Mongkolsapaya J, Dejnirattisai W, Xu XN, et al.: Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003;9:921-927.
32. Mangada MM, and Rothman AL: Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J Immunol 2005;175:2676-2683.
33. Jellison ER, Kim SK, and Welsh RM: Cutting edge: MHC class II-restricted killing in vivo during viral infection. J Immunol 2005;174:614-618.
34. Rothman AL, Kurane I, Lai CJ, et al.: Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T lymphocytes. J Virol 1993;67:801-806.
35. Green S, Vaughn DW, Kalayanarooj S, et al.: Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 1999;179:755-762.
36. Hober D, Poli L, Roblin B, et al.: Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am J Trop Med Hyg 1993;48:324-331.
37. Mangada MM, Endy TP, Nisalak A, et al.: Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. J Infect Dis 2002;185:1697-1703.
38. Gagnon SJ, Ennis FA, and Rothman AL: Bystander target cell lysis and cytokine production by dengue virus-specific human CD4 (+) cytotoxic T-lymphocyte clones. J Virol 1999;73:3623-3629.
39. Gagnon SJ, Mori M, Kurane I, et al.: Cytokine gene expression and protein production in peripheral blood mononuclear cells of children with acute dengue virus infections. J Med Virol 2002;67:41-46.
40. Brehm MA, Pinto AK, Daniels KA, et al.: T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat Immunol 2002;3:627-634.
41. Chen HD, Fraire AE, Joris I, et al.: Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol 2001;2:1067-1076.
42. Selin LK, Varga SM, Wong IC, and Welsh RM: Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J Exp Med 1998;188:1705-1715.
43. Welsh RM, and Fujinami RS: Pathogenic epitopes, heterologous immunity and vaccine design. Nat Rev Microbiol 2007;5:555-563.